Caldwell Trust’s Avanos Medical AVNS Stock Holding History

Caldwell Trust’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-12	Closed	-$139	–	755
2025 Q3	$139	Hold	12	–	–	﹤0.01%	749
2025 Q2	$147	Hold	12	–	–	﹤0.01%	745
2025 Q1	$172	Buy	+12	New	+$187	﹤0.01%	751
2023 Q2	–	Sell	-102	Closed	-$3.03K	–	760
2023 Q1	$3.03K	Hold	102	–	–	﹤0.01%	694
2022 Q4	$2.76K	Hold	102	–	–	﹤0.01%	689
2022 Q3	$2.22K	Hold	102	–	–	﹤0.01%	696
2022 Q2	$2.79K	Hold	102	–	–	﹤0.01%	707
2022 Q1	$3.42K	Hold	102	–	–	﹤0.01%	706
2021 Q4	$3.54K	Sell	102 -2	-2%	-$65	﹤0.01%	698
2021 Q3	$3.25K	Hold	104	–	–	﹤0.01%	690
2021 Q2	$3.78K	Hold	104	–	–	﹤0.01%	695
2021 Q1	$4.55K	Hold	104	–	–	﹤0.01%	676
2020 Q4	$4.77K	Hold	104	–	–	﹤0.01%	673
2020 Q3	$3.46K	Sell	104 -9	-8%	-$288	﹤0.01%	684
2020 Q2	$3.32K	Hold	113	–	–	﹤0.01%	718
2020 Q1	$3.04K	Hold	113	–	–	﹤0.01%	732
2019 Q4	$3.81K	Buy	+113	New	+$4.09K	﹤0.01%	759

Other funds holding AVNS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Caldwell Trust's AVNS Position: Q4 2025 in Review

Caldwell Trust sold out of Avanos Medical (AVNS) in Q4 2025, closing a stake of 12 shares — an estimated $139 sold.

Caldwell Trust first reported a position in AVNS in Q4 2019 and held it in 17 quarters. The position peaked at $4.77K in Q4 2020. 274 funds tracked by Wall St. Rank hold AVNS as of Q4 2025.

Caldwell Trust reported no remaining Avanos Medical position as of Q4 2025 after selling out during the quarter.
Caldwell Trust sold 12 Avanos Medical shares in Q4 2025, an estimated $139.
Caldwell Trust first reported a position in Avanos Medical in Q4 2019 and held it in 17 quarters.
Caldwell Trust's Avanos Medical position peaked at $4.77K in Q4 2020.
274 funds tracked by Wall St. Rank held Avanos Medical as of Q4 2025.

Based on Caldwell Trust's 13F filing for Q4 2025, filed 30 Jan 2026.